VascuMind | Could Blood Flow Be Affecting Your Memory?

Citicoline

Brain energy and cerebrovascular wellness support

MCI Screen Disclaimer

The MCI Screen referenced by VascuMind is a cognitive screening, benchmarking, and tracking tool sourced from MCI Screen / EMBIC materials. It does not diagnose vascular dementia or any other medical condition and is not a substitute for clinical evaluation. Results should be discussed with a qualified healthcare provider.

Supplement Disclaimer

These products are dietary supplements and are not intended to diagnose, treat, cure, or prevent vascular dementia, Alzheimer’s disease, MCI, stroke, or any other disease. Always consult your healthcare professional before use.

Always consult your healthcare professional before use, especially if you take medications or have a medical condition. VascuMind may earn a commission from qualifying purchases.

Certificate of Analysis / quality track

Protocol-ready citicoline should have batch COAs covering identity, potency, contaminants, and manufacturer quality documentation. Prefer branded or clinically characterized citicoline sources when commercially available.

Evidence context: review citicoline evidence in MCI / vascular-origin cognitive impairment. Evidence informs wellness positioning but does not establish a disease-related benefit for this product.

Quality & sourcing standards

Clinically characterized citicoline sources preferred (e.g., Cognizin® or equivalent)
Batch-specific Certificates of Analysis for identity, potency, heavy metals, microbial limits
Manufacturer GMP documentation and stability data available on request
Third-party testing verification for each production lot

Citicoline and Brain Energy

Citicoline is studied in cognitive-aging and vascular cognitive impairment contexts. VascuMind frames it as support for healthy brain energy and cognitive wellness, not as a disease-directed therapy.

Protocol role

Citicoline is the “brain energy” component of the Cerebrovascular Support stack and should be considered only after screening/benchmarking and clinician discussion.

How to review with your clinician

Bring the MCI Screen baseline and pattern-check summary to the visit
Discuss vascular risk factors: stroke/TIA history, hypertension, diabetes, PAD, small-vessel disease
Review current medications for interactions (especially anticholinergics, blood thinners)
Ask about citicoline evidence in vascular-origin cognitive impairment contexts
Request guidance on dosing, duration, and monitoring if appropriate for your situation

Quality verification checklist

Confirm branded/characterized citicoline source (e.g., Cognizin®)
Verify batch COA: identity, potency, heavy metals, microbial limits
Check GMP manufacturing documentation and stability data
Confirm third-party testing for each production lot

TRACK YOUR PROGRESS

Pair wellness changes with a memory screen

Establish a cognitive baseline and discuss results with a qualified healthcare professional. Educational only — not a diagnosis.

Start Memory Screen →

Private next step • clinician conversation support